Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NVAX compared with MRNA: revenue, margins and what each company keeps, and the suppliers and customers both name
NVAX
Novavax Inc
Change
Mkt cap
Revenue
Revenue
MRNA
Moderna, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
NVAX
Novavax Inc
vs
MRNA
Moderna, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
NVAX, solid
MRNA, dashed
NVAX
Novavax Inc
Change
9.51
· pre 9.53
· delayed
Mkt cap
$1.7B
Revenue
$57M
Q2 FY26
Revenue
$1.1B
FY25
MRNA
Moderna, Inc.
Change
220.15
· pre 221.69
· delayed
Pre-market
Nov 3 '26
delayed
Mkt cap
$88.5B
Revenue
$145M
Q2 FY26
Revenue
$1.9B
FY25
vs
Compare
Pre-market
Nov 3 '26
delayed
NVAX
Novavax Inc
vs
MRNA
Moderna, Inc.
9.51
pre 9.53
delayed
Price
220.15
pre 221.69
delayed
$1.7B
Mkt cap
$88.5B
Q2 FY26
$57M
Revenue
$145M
Q2 FY26
FY25
$1.1B
Revenue
$1.9B
FY25
Change
Change
NVAX
9.51
vs
MRNA
220.15
Pre-market
Nov 3 '26
delayed